A novel methuosis inducer DZ-514 possesses antitumor activity via activation of ROS-MKK4-p38 axis in triple negative breast cancer.

[1]  Li Yang,et al.  Triple negative breast cancer (TNBC): Non-genetic tumor heterogeneity and immune microenvironment: Emerging treatment options. , 2022, Pharmacology & therapeutics.

[2]  A. Jemal,et al.  Cancer statistics, 2022 , 2022, CA: a cancer journal for clinicians.

[3]  Yan Liang,et al.  JAC1 targets YY1 mediated JWA/p38 MAPK signaling to inhibit proliferation and induce apoptosis in TNBC , 2021, Cell death discovery.

[4]  L. Gianni,et al.  Treatment landscape of triple-negative breast cancer — expanded options, evolving needs , 2021, Nature Reviews Clinical Oncology.

[5]  Reena Philip,et al.  U.S. FDA Drug Approvals for Breast Cancer - A Decade in Review. , 2021, Clinical cancer research : an official journal of the American Association for Cancer Research.

[6]  Jacob T. Nearing,et al.  An in vivo genome‐wide shRNA screen identifies BCL6 as a targetable biomarker of paclitaxel resistance in breast cancer , 2021, Molecular oncology.

[7]  C. Denkert,et al.  Breast cancer , 2021, The Lancet.

[8]  Mingyao Liu,et al.  BCL6 confers KRAS-mutant non-small-cell lung cancer resistance to BET inhibitors. , 2021, The Journal of clinical investigation.

[9]  Mingtao Ao,et al.  Design, synthesis, and biological evaluation of 5-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)-1H-Indole-2-Carbohydrazide derivatives: the methuosis inducer 12A as a Novel and selective anticancer agent , 2021, Journal of enzyme inhibition and medicinal chemistry.

[10]  Mingjun Wu,et al.  BTB/POZ zinc finger protein ZBTB16 inhibits breast cancer proliferation and metastasis through upregulating ZBTB28 and antagonizing BCL6/ZBTB27 , 2020, Clinical Epigenetics.

[11]  W. El-Deiry,et al.  Targeting apoptosis in cancer therapy , 2020, Nature Reviews Clinical Oncology.

[12]  E. Smythe,et al.  Water loss regulates cell and vesicle volume , 2020, Science.

[13]  Mingyao Liu,et al.  Synthesis and Biological Evaluation of B-Cell Lymphoma 6 Inhibitors of N-phenyl-4-pyrimidinamine Derivatives Bearing Potent Activities against Tumor Growth. , 2020, Journal of medicinal chemistry.

[14]  M. Athar,et al.  Combined mTORC1/mTORC2 inhibition blocks growth and induces catastrophic macropinocytosis in cancer cells , 2019, Proceedings of the National Academy of Sciences.

[15]  B. Győrffy,et al.  BCL6 Evolved to Enable Stress Tolerance in Vertebrates and Is Broadly Required by Cancer Cells to Adapt to Stress. , 2019, Cancer discovery.

[16]  A. F. Castro,et al.  CK2 inhibition with silmitasertib promotes methuosis-like cell death associated to catastrophic massive vacuolization of colorectal cancer cells , 2019, Cell Death & Disease.

[17]  P. Erhardt,et al.  The JNK signaling pathway plays a key role in methuosis (non-apoptotic cell death) induced by MOMIPP in glioblastoma , 2019, BMC Cancer.

[18]  L. V. van Bogaert.  Breast cancer , 2019, Nature Reviews Disease Primers.

[19]  W. Eiermann,et al.  Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation , 2018, The New England journal of medicine.

[20]  M. Hild,et al.  Indolyl-Pyridinyl-Propenone-Induced Methuosis through the Inhibition of PIKFYVE , 2018, ACS omega.

[21]  B. Li,et al.  An Ursolic Acid Derived Small Molecule Triggers Cancer Cell Death through Hyperstimulation of Macropinocytosis. , 2017, Journal of medicinal chemistry.

[22]  M. Robson,et al.  Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation , 2017, The New England journal of medicine.

[23]  Qifeng Yang,et al.  MicroRNA-544 down-regulates both Bcl6 and Stat3 to inhibit tumor growth of human triple negative breast cancer , 2016, Biological chemistry.

[24]  R. Insall,et al.  WASH drives early recycling from macropinosomes and phagosomes to maintain surface phagocytic receptors , 2016, Proceedings of the National Academy of Sciences.

[25]  J. Xie,et al.  BCL6 induces EMT by promoting the ZEB1-mediated transcription repression of E-cadherin in breast cancer cells. , 2015, Cancer letters.

[26]  R. Botelho,et al.  The Phosphoinositide‐Gated Lysosomal Ca2+ Channel, TRPML1, Is Required for Phagosome Maturation , 2015, Traffic.

[27]  Eugenia G. Giannopoulou,et al.  The transcriptional modulator BCL6 as a molecular target for breast cancer therapy , 2014, Oncogene.

[28]  H. Arai,et al.  Small GTPases and phosphoinositides in the regulatory mechanisms of macropinosome formation and maturation , 2014, Front. Physiol..

[29]  W. Maltese,et al.  Methuosis: nonapoptotic cell death associated with vacuolization of macropinosome and endosome compartments. , 2014, The American journal of pathology.

[30]  Amy R. Peck,et al.  Prolactin suppresses a progestin-induced CK5-positive cell population in luminal breast cancer through inhibition of progestin-driven BCL6 expression , 2013, Oncogene.

[31]  K. Hahn,et al.  A RhoC Biosensor Reveals Differences in the Activation Kinetics of RhoA and RhoC in Migrating Cells , 2013, PloS one.

[32]  Peter J Hume,et al.  Arf6 coordinates actin assembly through the WAVE complex, a mechanism usurped by Salmonella to invade host cells , 2013, Proceedings of the National Academy of Sciences.

[33]  M. Fujii,et al.  Dissecting the roles of Rac1 activation and deactivation in macropinocytosis using microscopic photo-manipulation , 2013, Scientific Reports.

[34]  A. Helenius,et al.  Gulping rather than sipping: macropinocytosis as a way of virus entry. , 2012, Current opinion in microbiology.

[35]  J. Swanson,et al.  A growth factor signaling cascade confined to circular ruffles in macrophages , 2012, Biology Open.

[36]  P. Erhardt,et al.  Synthesis and evaluation of indole-based chalcones as inducers of methuosis, a novel type of nonapoptotic cell death. , 2012, Journal of medicinal chemistry.

[37]  P. Gleeson,et al.  Macropinocytosis: an endocytic pathway for internalising large gulps , 2011, Immunology and cell biology.

[38]  W. Maltese,et al.  A chalcone-related small molecule that induces methuosis, a novel form of non-apoptotic cell death, in glioblastoma cells , 2011, Molecular Cancer.

[39]  Philippe P Roux,et al.  Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein Kinases , 2011, Microbiology and Molecular Reviews.

[40]  K. Christensen,et al.  Lucifer Yellow as a Live Cell Fluorescent Probe for Imaging Water Transport in Subcellular Organelles , 2011, Applied spectroscopy.

[41]  Roger L. Williams,et al.  Finding a fitting shoe for Cinderella , 2010 .

[42]  K. Shokat,et al.  PIKfyve Regulation of Endosome-Linked Pathways , 2009, Traffic.

[43]  Zhongmei Zhou,et al.  WW domain-containing E3 ubiquitin protein ligase 1 targets p63 transcription factor for ubiquitin-mediated proteasomal degradation and regulates apoptosis , 2008, Cell Death and Differentiation.

[44]  Erin E. Johnson,et al.  Active Ras Triggers Death in Glioblastoma Cells through Hyperstimulation of Macropinocytosis , 2008, Molecular Cancer Research.

[45]  Guan Chen,et al.  The p38 MAPK stress pathway as a tumor suppressor or more? , 2008, Frontiers in bioscience : a journal and virtual library.

[46]  A. Luini,et al.  The closure of Pak1‐dependent macropinosomes requires the phosphorylation of CtBP1/BARS , 2008, The EMBO journal.

[47]  Y. Kloog,et al.  A unique platform for H-Ras signaling involving clathrin-independent endocytosis. , 2007, Molecular biology of the cell.

[48]  G. Kreitzer,et al.  Organization of vesicular trafficking in epithelia , 2005, Nature Reviews Molecular Cell Biology.

[49]  J. Wands,et al.  Uncoupling protein‐2 deficiency promotes oxidant stress and delays liver regeneration in mice , 2004, Hepatology.

[50]  Nobuyuki Tanaka,et al.  Mechanism of p38 MAP kinase activation in vivo. , 2003, Genes & development.

[51]  S. Yokoyama,et al.  Oncogenic Ras triggers cell suicide through the activation of a caspase-independent cell death program in human cancer cells , 1999, Oncogene.

[52]  Y. Moriyama,et al.  Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells. , 1998, Cell structure and function.

[53]  Yong Jiang,et al.  Characterization of the Structure and Function of the Fourth Member of p38 Group Mitogen-activated Protein Kinases, p38δ* , 1997, The Journal of Biological Chemistry.

[54]  Jiahuai Han,et al.  The primary structure of p38 gamma: a new member of p38 group of MAP kinases. , 1996, Biochemical and biophysical research communications.

[55]  Wei Guo,et al.  Characterization of the Structure and Function of a New Mitogen-activated Protein Kinase (p38β)* , 1996, The Journal of Biological Chemistry.

[56]  R. Davis,et al.  MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway , 1996, Molecular and cellular biology.

[57]  Jiahuai Han,et al.  Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms , 1995, Science.

[58]  L Bibbs,et al.  A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. , 1994, Science.

[59]  K Offit,et al.  Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma. , 1993, Science.

[60]  H. Tilly,et al.  LAZ3, a novel zinc–finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas , 1993, Nature Genetics.

[61]  K. Altendorf,et al.  Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[62]  D. Bar-Sagi,et al.  Induction of membrane ruffling and fluid-phase pinocytosis in quiescent fibroblasts by ras proteins. , 1986, Science.